CellSeed

About:

CellSeed is a biotechnology company that produces a number of cell sheet regenerative medicine products, including cell culture equipment.

Website: http://cellseed.com

Top Investors: SBI Investment, SMBC Venture Capital, Mitsubishi UFJ Capital, Nissay Capital, Shoko Chukin Bank

Description:

CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment of osteoarthritis The company was founded in 2001 and is headquartered in Tokyo, Japan.

Total Funding Amount:

3.17B JPY

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2001-05-01

Founders:

Yukio Hasegawa

Number of Employees:

11-50

Last Funding Date:

2014-03-04

IPO Status:

Public

Industries:

© 2025 bioDAO.ai